Indications for lowering platelet numbers in essential thrombocythemia

被引：9

作者：

Barbui, T ^{[1
]}

机构：

[1] Osped Riuniti Bergamo, Dept Hematol, I-24100 Bergamo, Italy

来源：

SEMINARS IN HEMATOLOGY | 2003年 / 40卷 / 01期

关键词：

D O I：

10.1053/shem.2003.50030

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：22 / 25

页数：4

共 31 条

[1] Barbui T, 1999, SEMIN HEMATOL, V36, P14
[2] THROMBOHEMORRHAGIC COMPLICATIONS IN 101 CASES OF MYELOPROLIFERATIVE DISORDERS - RELATIONSHIP TO PLATELET NUMBER AND FUNCTION
BARBUI, T
CORTELAZZO, S
VIERO, P
BASSAN, R
DINI, E
SEMERARO, N
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (11): : 1593 - 1599
[3] COLOMBI M, 1991, CANCER-AM CANCER SOC, V67, P2926, DOI 10.1002/1097-0142(19910601)67:11<2926::AID-CNCR2820671136>3.0.CO
[4] 2-3
[5] HYDROXYUREA FOR PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND A HIGH-RISK OF THROMBOSIS
CORTELAZZO, S
FINAZZI, G
RUGGERI, M
VESTRI, O
GALLI, M
RODEGHIERO, F
BARBUI, T
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (17) : 1132 - 1136
[6] INCIDENCE AND RISK-FACTORS FOR THROMBOTIC COMPLICATIONS IN A HISTORICAL COHORT OF 100 PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
CORTELAZZO, S
VIERO, P
FINAZZI, G
DEMILIO, A
RODEGHIERO, F
BARBUI, T
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (03) : 556 - 562
[7] Interferon-α therapy in polycythemia vera and essential thrombocythemia
Elliott, MA
Tefferi, A
[J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (05) : 463 - 472
[8] Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long-term follow-up of a randomized clinical trial
Finazzi, G
Ruggeri, M
Rodeghiero, F
Barbui, T
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (03) : 577 - 583
[9] Gilbert HS, 1998, CANCER-AM CANCER SOC, V83, P1205, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1205::AID-CNCR21>3.0.CO
[10] 2-8

← 1 2 3 4 →